Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMDW) Inventory (2023 - 2025)

Baird Medical Investment Holdings' quarterly Inventory came in at $1.1 million in Q4 2025, down 16.26% year-on-year from $1.3 million in Q4 2024, and up 1106.64% quarter-over-quarter from -$107862.0 in Q2 2025.

Baird Medical Investment Holdings has reported Inventory for 3 years, with the latest figure at $1.1 million in Q4 2025.

  • For the quarter ending Q4 2025, Inventory fell 16.26% year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2025 stood at $1.1 million (down 16.26% YoY), and the FY2025 full-year result was $1.1 million, down 16.26% from the prior year.
  • Inventory for Q4 2025 stood at $1.1 million, up from -$107862.0 in the prior quarter.
  • The five-year high for Inventory was $1.3 million in Q4 2024, with the low at -$107862.0 in Q2 2025.
  • Average Inventory over 3 years is $682970.6, with a median of $1.1 million recorded in 2025.
  • Year-over-year, Inventory rose 13.48% in 2024 and slumped 4771.82% in 2025.
  • Tracing BDMDW's Inventory over 3 years: stood at $1.1 million in 2023, then advanced by 13.48% to $1.3 million in 2024, then dropped by 16.26% to $1.1 million in 2025.
  • The last three Inventory figures came in at $1.1 million (Q4 2025), -$107862.0 (Q2 2025), and $1.3 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.99 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 5.42 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.31 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.12 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.12 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.64 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 693.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 2.35 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 631.80 Mn
10 Baird Medical Investment Holdings - - - 1.09 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 1.09 Mn
Jun 30, 2025 -107,862.00
Dec 31, 2024 1.30 Mn
Jun 30, 2024 -2,214.00
Dec 31, 2023 1.14 Mn